Health ❯ Public Health

Drug Policy

Fentanyl Crisis Harm Reduction Opioid Crisis Substance Abuse Health Risks Drug Deaths Decriminalization Cannabis Legislation Overdose Prevention Naloxone Distribution Marijuana Health Sciences Authority Synthetic Drugs Marijuana Rescheduling Youth Programs Drug Testing Recreational Drug Use Cannabis Effects Medicare Marijuana Restrictions Synthetic Opioids Marijuana Legalization FDA Regulations Cannabis Legalization Cannabis Regulation Medical Treatment Illicit Drugs Regulation of Substances Criminal Penalties Impact of Convictions Drug-Related Deaths Access to Medication Health Minister Substance Regulation Addiction Issues Addiction Opioid Use Drug Consumption Facilities Decriminalization Impact Drug Alerts Community Health Research Funding Prevention Strategies Substance Use Cannabis Use Germany Safer Supply Drug Regulation Medical Marijuana Cannabis Policy Fentanyl Drug Decriminalization Survey Methodology Addiction Treatment Xylazine Regulation Regional Drug Plan Charity Funding FDA Actions Pill Testing Health Risks of Cannabis Rehabilitation Monitoring Trends Cannabis

U.S. Teen Substance Use Stays Near Record Lows for Fifth Year, With Small Upticks in Heroin and Cocaine

Researchers attribute the sustained drop to pandemic-era shifts in teen routines.

Trump Awards First Mexican Border Defense Medals to 13 Service Members

Medetomidine Tied to Penn North Mass Overdose as Baltimore Updates Response Guidance

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research